Free Trial
NASDAQ:MDWD

MediWound (MDWD) Stock Price, News & Analysis

MediWound logo
$16.96 -0.29 (-1.68%)
As of 09:41 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About MediWound Stock (NASDAQ:MDWD)

Advanced

Key Stats

Today's Range
$16.91
$17.41
50-Day Range
$16.29
$21.00
52-Week Range
$14.14
$22.50
Volume
97,848 shs
Average Volume
153,838 shs
Market Capitalization
$183.34 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$32.25
Consensus Rating
Moderate Buy

Company Overview

MediWound Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
31st Percentile Overall Score

MDWD MarketRank™: 

MediWound scored higher than 31% of companies evaluated by MarketBeat, and ranked 775th out of 944 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    MediWound has received a consensus rating of Moderate Buy. The company's average rating score is 2.80, and is based on 4 buy ratings, 1 hold rating, and no sell ratings.

  • Upside Potential

    MediWound has a consensus price target of $32.25, representing about 89.9% upside from its current price of $16.98.

  • Amount of Analyst Coverage

    MediWound has only been the subject of 1 research reports in the past 90 days.

  • Read more about MediWound's stock forecast and price target.
  • Earnings Growth

    Earnings for MediWound are expected to grow in the coming year, from ($2.66) to ($2.24) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of MediWound is -6.43, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of MediWound is -6.43, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    MediWound has a P/B Ratio of 5.88. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about MediWound's valuation and earnings.
  • Percentage of Shares Shorted

    11.71% of the float of MediWound has been sold short.
  • Short Interest Ratio / Days to Cover

    MediWound has a short interest ratio ("days to cover") of 10.8, which indicates bearish sentiment.
  • Change versus previous month

    Short interest in MediWound has recently increased by 8.72%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    MediWound does not currently pay a dividend.

  • Dividend Growth

    MediWound does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    11.71% of the float of MediWound has been sold short.
  • Short Interest Ratio / Days to Cover

    MediWound has a short interest ratio ("days to cover") of 10.8, which indicates bearish sentiment.
  • Change versus previous month

    Short interest in MediWound has recently increased by 8.72%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    MediWound has a news sentiment score of 0.90. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.76 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 3 news articles for MediWound this week, compared to 2 articles on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, MediWound insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 9.20% of the stock of MediWound is held by insiders.

  • Percentage Held by Institutions

    46.83% of the stock of MediWound is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about MediWound's insider trading history.
Receive MDWD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for MediWound and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

MDWD Stock News Headlines

Nvidia Times 1,000,000
Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 trillion calculations per second. Elon Musk and Nvidia’s Jensen Huang are now teaming up to deploy one million of these chips inside what could become the most advanced AI machine on the planet. But according to James Altucher, the real opportunity isn’t in Tesla or Nvidia. He’s uncovered a little-known company that Musk, Nvidia, and even 98% of the Fortune 500 already rely on to make AI 2.0 possible. Nvidia’s CEO has even called this company “essential” to their expansion.tc pixel
MediWound Is A Buy Opportunity On The Dip
See More Headlines

MDWD Stock Analysis - Frequently Asked Questions

MediWound's stock was trading at $17.80 at the beginning of 2025. Since then, MDWD stock has decreased by 4.6% and is now trading at $16.98.

MediWound Ltd. (NASDAQ:MDWD) issued its quarterly earnings results on Thursday, August, 14th. The biopharmaceutical company reported ($1.23) earnings per share for the quarter, missing the consensus estimate of ($0.55) by $0.68. The biopharmaceutical company earned $5.71 million during the quarter, compared to analyst estimates of $5.68 million. MediWound had a negative net margin of 142.18% and a negative trailing twelve-month return on equity of 96.71%.
Read the conference call transcript
.

Shares of MediWound reverse split on the morning of Tuesday, December 20th 2022.The 1-7 reverse split was announced on Tuesday, December 20th 2022. The number of shares owned by shareholders was adjusted after the market closes on Tuesday, December 20th 2022. An investor that had 100 shares of stock prior to the reverse split would have 14 shares after the split.

MediWound's top institutional shareholders include Yelin Lapidot Holdings Management Ltd. (7.56%), Rosalind Advisors Inc. (3.77%), Silverberg Bernstein Capital Management LLC (1.36%) and Geode Capital Management LLC (0.92%).

Shares of MDWD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that MediWound investors own include NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), Broadcom (AVGO), Adobe (ADBE), ServiceNow (NOW) and Palo Alto Networks (PANW).

Company Calendar

Last Earnings
8/14/2025
Today
9/21/2025
Next Earnings (Estimated)
11/25/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - DRUGS
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:MDWD
CIK
1593984
Employees
80
Year Founded
2001

Price Target and Rating

High Price Target
$39.00
Low Price Target
$25.00
Potential Upside/Downside
+89.9%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.80
Research Coverage
5 Analysts

Profitability

EPS (Trailing Twelve Months)
($2.64)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$30.22 million
Net Margins
-142.18%
Pretax Margin
-141.77%
Return on Equity
-96.71%
Return on Assets
-39.73%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
1.48
Quick Ratio
1.35

Sales & Book Value

Annual Sales
$20.22 million
Price / Sales
9.08
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$2.89 per share
Price / Book
5.88

Miscellaneous

Outstanding Shares
10,810,000
Free Float
9,814,000
Market Cap
$183.55 million
Optionable
Optionable
Beta
0.25

Social Links

(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report

This page (NASDAQ:MDWD) was last updated on 9/22/2025 by MarketBeat.com Staff
From Our Partners